ES2148561T3 - Prevencion y curacion de enfermedades alergicas de tipo i. - Google Patents

Prevencion y curacion de enfermedades alergicas de tipo i.

Info

Publication number
ES2148561T3
ES2148561T3 ES95933609T ES95933609T ES2148561T3 ES 2148561 T3 ES2148561 T3 ES 2148561T3 ES 95933609 T ES95933609 T ES 95933609T ES 95933609 T ES95933609 T ES 95933609T ES 2148561 T3 ES2148561 T3 ES 2148561T3
Authority
ES
Spain
Prior art keywords
sub
branched
linear
allergic diseases
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933609T
Other languages
English (en)
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of ES2148561T3 publication Critical patent/ES2148561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

COMPOSICION PARA PREVENIR O TRATAR ENFERMEDADES ALERGICAS DEL TIPO I QUE CONTIENEN COMO INGREDIENTE ACTIVO UN COMPUESTO DE ANILIDO REPRESENTADO POR LA FORMULA GENERAL (I), UN ESTEREOISOMERO DE LA MISMA, O UNA SAL ACEPTABLE FARMACEUTICAMENTE DE LA MISMA; DONDE R{SUB,1} REPRESENTA TRIFLUOROMETIL, HALOGENO O CIANO; R{SUB,2} REPRESENTA HIDROGENO O ALQUIL C{SUB,1}-C{SUB,4} LINEAL O RAMIFICADO, Y R{SUB,3} REPRESENTA UN GRUPO REPRESENTADO POR LA FORMULA GENERAL (II) O (III), DONDE R{SUB,4} REPRESENTA ALQUIL C{SUB,1}-C{SUB,4} LINEAL O RAMIFICADO, ALQUENIL C{SUB,2}C{SUB,6} LINEAL O RAMIFICADO, ALQUINIL C{SUB,2}-C{SUB,6} LINEAL O RAMIFICADO, O CICLOALQUIL C{SUB,3}-C{SUB,7}. LA COMPOSICION PUEDE PREVENIR DE FORMA RADICAL O TRATAR ENFERMEDADES ALERGICAS DEL TIPO I MEDIANTE LA INHIBICION DE LA PRODUCCION DE IGE COMO CAUSA DIRECTA DE ESTAS ENFERMEDADES.
ES95933609T 1994-10-17 1995-10-04 Prevencion y curacion de enfermedades alergicas de tipo i. Expired - Lifetime ES2148561T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17

Publications (1)

Publication Number Publication Date
ES2148561T3 true ES2148561T3 (es) 2000-10-16

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933609T Expired - Lifetime ES2148561T3 (es) 1994-10-17 1995-10-04 Prevencion y curacion de enfermedades alergicas de tipo i.

Country Status (19)

Country Link
US (1) US5814649A (es)
EP (1) EP0787491B1 (es)
KR (1) KR100365064B1 (es)
AT (1) ATE194912T1 (es)
AU (1) AU695907B2 (es)
CA (1) CA2202904C (es)
DE (1) DE69518159T2 (es)
DK (1) DK0787491T3 (es)
ES (1) ES2148561T3 (es)
FI (1) FI971584A7 (es)
GR (1) GR3034413T3 (es)
HU (1) HU222888B1 (es)
IL (1) IL115617A (es)
NO (1) NO315928B1 (es)
NZ (1) NZ293691A (es)
PT (1) PT787491E (es)
TW (1) TW429146B (es)
WO (1) WO1996011682A1 (es)
ZA (1) ZA958708B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903345B1 (de) * 1997-08-08 2000-10-04 Aventis Pharma Deutschland GmbH Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
AU747815B2 (en) 1998-02-19 2002-05-23 Kowa Co., Ltd. Cyclic amide compounds
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2002034251A1 (en) * 2000-10-20 2002-05-02 Parker Hughes Institute Treatment of asthma with lfm analogues
US20010026800A1 (en) * 2000-01-07 2001-10-04 Michael Jacob G. Selective activation of a TH1 or TH2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
NZ598744A (en) 2009-09-18 2013-11-29 Sanofi Sa (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (es) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
ATE194912T1 (de) 2000-08-15
NO971743L (no) 1997-04-16
NO315928B1 (no) 2003-11-17
DE69518159T2 (de) 2002-01-03
FI971584A0 (fi) 1997-04-15
ZA958708B (en) 1996-05-14
CA2202904A1 (en) 1996-04-25
HUT77135A (hu) 1998-03-02
DK0787491T3 (da) 2000-10-16
KR970706811A (ko) 1997-12-01
FI971584L (fi) 1997-04-15
EP0787491A4 (en) 1998-09-30
DE69518159D1 (de) 2000-08-31
FI971584A7 (fi) 1997-04-15
EP0787491A1 (en) 1997-08-06
PT787491E (pt) 2000-11-30
HU222888B1 (hu) 2003-12-29
AU3618695A (en) 1996-05-06
AU695907B2 (en) 1998-08-27
GR3034413T3 (en) 2000-12-29
CA2202904C (en) 2006-12-19
WO1996011682A1 (en) 1996-04-25
US5814649A (en) 1998-09-29
TW429146B (en) 2001-04-11
NO971743D0 (no) 1997-04-16
EP0787491B1 (en) 2000-07-26
KR100365064B1 (ko) 2003-04-11
IL115617A (en) 1999-11-30
NZ293691A (en) 1999-07-29
IL115617A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
MX9305812A (es) 3-(2-aciloxietoxifenil)benzofuran-2-onas para utilizarse como estabilizantes.
ES2038752T3 (es) Procedimiento para preparar acetilenos disustituidos con un grupo fenilo y un grupo heterobiciclico, que tienen actividad de tipo retinoide.
ES2153927T3 (es) Intermedios de dioxolano.
DK1485359T3 (da) Natriumkanalblokkere
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
BR0313942A (pt) Derivados de benzimidazol úteis como agentes antiproliferativos
ES2148561T3 (es) Prevencion y curacion de enfermedades alergicas de tipo i.
CR7877A (es) Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
ES2153491T3 (es) Derivados de quinazolina.
ATE460394T1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
ES2180933T3 (es) Inhibidor de la serina-proteasa.
FR2767525B1 (fr) Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2143181T3 (es) Derivados biciclicos de isotiourea utiles en terapia.
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
ES2170804T3 (es) Derivados de dihidro-2,3-benzodiazepina.
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
ES2062860T3 (es) Composicion farmaceutica para la mejoria de la disuria.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 787491

Country of ref document: ES